1. Home
  2. NTLA vs FNKO Comparison

NTLA vs FNKO Comparison

Compare NTLA & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • FNKO
  • Stock Information
  • Founded
  • NTLA 2014
  • FNKO 2017
  • Country
  • NTLA United States
  • FNKO United States
  • Employees
  • NTLA N/A
  • FNKO N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • FNKO Recreational Games/Products/Toys
  • Sector
  • NTLA Health Care
  • FNKO Consumer Discretionary
  • Exchange
  • NTLA Nasdaq
  • FNKO Nasdaq
  • Market Cap
  • NTLA 710.1M
  • FNKO 708.1M
  • IPO Year
  • NTLA 2016
  • FNKO 2017
  • Fundamental
  • Price
  • NTLA $8.12
  • FNKO $3.51
  • Analyst Decision
  • NTLA Buy
  • FNKO Strong Buy
  • Analyst Count
  • NTLA 19
  • FNKO 3
  • Target Price
  • NTLA $38.26
  • FNKO $11.33
  • AVG Volume (30 Days)
  • NTLA 3.2M
  • FNKO 1.1M
  • Earning Date
  • NTLA 05-08-2025
  • FNKO 05-08-2025
  • Dividend Yield
  • NTLA N/A
  • FNKO N/A
  • EPS Growth
  • NTLA N/A
  • FNKO N/A
  • EPS
  • NTLA N/A
  • FNKO N/A
  • Revenue
  • NTLA $45,569,000.00
  • FNKO $1,024,890,000.00
  • Revenue This Year
  • NTLA N/A
  • FNKO $3.25
  • Revenue Next Year
  • NTLA N/A
  • FNKO $8.30
  • P/E Ratio
  • NTLA N/A
  • FNKO N/A
  • Revenue Growth
  • NTLA N/A
  • FNKO N/A
  • 52 Week Low
  • NTLA $5.90
  • FNKO $3.79
  • 52 Week High
  • NTLA $28.18
  • FNKO $14.65
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 50.39
  • FNKO 29.15
  • Support Level
  • NTLA $7.21
  • FNKO $3.79
  • Resistance Level
  • NTLA $9.27
  • FNKO $4.33
  • Average True Range (ATR)
  • NTLA 0.61
  • FNKO 0.28
  • MACD
  • NTLA 0.02
  • FNKO 0.14
  • Stochastic Oscillator
  • NTLA 44.20
  • FNKO 0.97

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About FNKO Funko Inc.

Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

Share on Social Networks: